Exane Derivatives’s Centrus Energy LEU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$946K Buy
38,214
+18,929
+98% +$523K 0.54% 45
2022
Q1
$650K Sell
19,285
-13,541
-41% -$569K 0.18% 150
2021
Q4
$1.64M Buy
32,826
+23,662
+258% +$1.32M 0.4% 49
2021
Q3
$354K Buy
9,164
+217
+2% +$6.02K 0.09% 250
2021
Q2
$222K Buy
8,947
+528
+6% +$12.6K 0.05% 371
2021
Q1
$200K Sell
8,419
-978
-10% -$23.4K 0.06% 298
2020
Q4
$217K Buy
+9,397
New +$131K 0.06% 301

Other funds holding LEU

Exane Derivatives's LEU Position: Q2 2022 in Review

Exane Derivatives increased its Centrus Energy (LEU) stake by 98% in Q2 2022, buying an estimated $523K and bringing the position to 38,214 shares worth $946K. The position accounts for 0.54% of the portfolio, ranked #45.

Exane Derivatives first reported a position in LEU in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.64M in Q4 2021. 71 funds tracked by Wall St. Rank hold LEU as of Q2 2022.

  • Exane Derivatives held 38,214 shares of Centrus Energy worth $946K as of Q2 2022.
  • Exane Derivatives bought 18,929 Centrus Energy shares in Q2 2022, an estimated $523K.
  • Centrus Energy made up 0.54% of Exane Derivatives's portfolio in Q2 2022, its #45 holding.
  • Exane Derivatives first reported a position in Centrus Energy in Q4 2020 and has held it in 7 quarters since.
  • Exane Derivatives's Centrus Energy position peaked at $1.64M in Q4 2021.
  • 71 funds tracked by Wall St. Rank held Centrus Energy as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.